with the High Sponsorship of CPLP

 Visit our Archive

  ISSN (electronic)

2182-2379

BBRCapa20(1)

Journal DOI: 10.19277/bbr

 

Journal Information 

The journal Biomedical and Biopharmaceutical Research | Investigação Biomédica e Biofarmacêutica (BBR | IBB) is an international, bilingual, peer-reviewed scientific publication created with the main objective of promoting the progress of society through health-related knowledge. BBR | IBB is proud to be distinguished with the High Sponsorship of the CPLP (Community of Portuguese Speaking Countries). The journal is owned by ALIES, a non-profit cultural organisation (read more about ALIES here).

In the fields of biomedical sciences and biopharmaceuticals, BBR | IBB's research interests focus on environmental, social, educational, behavioural, technological and political perspectives to promote human health and prevent disease in individuals and their communities.

BBR | IBB is present in several databases - Scopus, Portuguese Medical Journals, SciElo, UNIVERSIA, LATINDEX, KOSMET Index, FSTA®, Thomson Reuters, PMC, Index Copernicus, Google Scholar, mEDRA, among others. The application to other databases is in progress.

Please see the publication details, including ISSN and publication quartiles for BBR | IBB [ + here].

BBR | IBB is an independent open-access publication, free to readers, centred on high-quality research, promoting diversity, fairness and equality, and guided by the highest ethical standards in human medical research.

 

Scope

The scope of BBR | IBB reflects a fundamental/integrative research character, serving as a platform for the exchange of knowledge through the publication of original articles, reviews and case reports. The diversity of the topics of our articles reflects the many ways, from classic to creative to cutting-edge, to support the various needs of human health. These topics include

  • Education, Behaviour, Lifestyle and Well-being
  • Nutrition and Food Sciences
  • Pharmacology, Therapeutics and Toxicology
  • Pharmacotechnology and Nanotechnology
  • Physiology and Medicine
  • Health and Digital Innovation
  • Medicinal Chemistry and Natural Products
  • Technology, Sensors and Methods of Analysis

At the Editor's discretion, research papers on more applied topics may be included.

BBR | IBB seeks to promote the application of research in everyday practice and particularly values open science and interdisciplinary collaboration. IBB | BBR welcomes articles with translational potential on biomedical and biopharmaceutical issues, favouring research centred on new insights into structural issues with an impact on health policies and systems, new molecules (natural or synthetic) with the potential to address major disease problems, or new insights into processes around disease mechanisms with a potential impact on diagnostics and/or therapeutics.

 

Competing Interests

Editors do not receive any salary for their work at BBR | IBB. Even so, Editors are required to declare all relevant competing interests and are excluded from participation in the review of any submission for which they have a competing interest.

 

Publication Fees

BBR | IBB does not charge any costs or fees for the submission and publication of manuscripts by Portuguese-speaking authors. For other authors, an English version is sufficient for submission. However, BBR | IBB does not accept automatic translations (Google Translate, DeepL, others), which means that the Portuguese version will be the direct responsibility of the Editorial Office. In this case, a fee will be charged to ensure this purpose (please see [+ here] under "Submission and publication costs").

 

Ethics and Good Publication Practices

BBR | IBB fully assumes all its ethical duties and responsibilities at all stages of publication. Our editorial options and policies are detailed [ + here ].

Publication priorities and decisions are made taking into account the quality, originality and usefulness of the manuscripts submitted. However, we are aware that more inclusive policies are needed to change the imbalances recognised in biomedical publications. BBR | IBB is continually committed to promoting diversity and inclusion, a concern addressed by a constant demand for authors and editors from smaller or developing communities, particularly in ‘Lusophone’ countries. The same awareness has shaped the expansion of equity and equality (gender, religious, social, cultural, racial) of our editorial board.

 

Reproduction rights and publication

BBR | IBB is an open access publisher that adopts the CC BY-NC (Creative Commons) distribution license [see more here] and all articles are immediately and permanently accessible, after acceptance, online in open format, free of charge and without any kind of cost or registration.

 

Contact

Visit the BBR | IBB contact page for more information [+here].